Ads by Google
Increasing or maintaining activity levels may help premenopausal patients avoid the weight gain common with chemotherapy for breast cancer.
Women with benign breast disease have a higher risk for breast cancer, and that certain types of breast disease may predict the near term development of breast cancer.
Researchers have discovered new evidence about how the microenvironment of breast cancers helps drive the cancers' growth and migration.
Families with a history of lobular breast cancer have an even greater risk of breast cancer and may need more thorough screening.
If told they were at high risk of developing breast cancer, one in five women would consider having both breasts removed to help reduce their risk of developing breast cancer.
Recent studies show the drug Herceptin holds huge promise for women with a particularly aggressive type of breast cancer.
Discovery of a mechanism blocks the body's natural ability to reject breast cancer, creates new options for treatment.
Breast cancer tumors that stop responding to the drug tamoxifen actually change their cellular characteristics and become responsive to other types of drugs.
While breast cancer is a significant health threat, a new study finds most women have a distorted view of their risk.
Not every breast cancer patient needs chemotherapy, but for those who do, this discovery may be helpful in more accurately predicting who will go into early menopause.
A new class of anti cancer drugs that has rarely helped breast cancer patients may perform poorly because of the mutations in a gene the drugs are designed to target.
Breast cancer recurrence may be decreased by Low Fat Diet, evidence suggests.
Genomic Test Predicted Breast Cancer's Spread to Lymph Nodes With 90 Percent Accuracy in Most Women, Duke Study Showed.
Herceptin(R) combined with Chemotherapy improves disease free survival for patients with Early Stage Breast Cancer
Jeremy McCormick was just 12 years old when his mother's breast cancer struck.
Bevacizumba Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
This study is the first to find a benefit of anti angiogenic therapy in patients with breast cancer and represents a major advance in the treatment of patients with metastatic disease.
Half of women at high risk of developing breast cancer have a specific alteration in their breast cells indicating significant damage has occurred and breast cancer may be imminent.
Early detection should enable doctors to more successfully treat breast cancer before it has formed a tumor.
Women with breast cancer have fewer adverse effects from chemotherapy and less fatigue when using virtual reality as a distraction intervention during treatments.
Decompression chambers may hold the key to relieving painful side effects of breast cancer treatment.
Many scientists have linked specific gene alterations with the development of breast cancer. But further than that, scientists are unclear as to how breast cancers arise.
Their findings suggest that estrogen and progestin alone may not be the sole triggers for the increased risk of invasive breast cancers in postmenopausal women who take hormone replacement therapy.
Research found that women with a common thyroid gland disorder appear to have a reduced chance of developing invasive breast cancer.